These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1932607)
1. Comparative bioavailability of two flurbiprofen products: stereospecific versus conventional approach. Jamali F; Collins DS; Berry BW; Molder S; Cheung R; McColl K; Cheung H Biopharm Drug Dispos; 1991; 12(6):435-45. PubMed ID: 1932607 [TBL] [Abstract][Full Text] [Related]
2. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers. Ahmad M; Pervaiz F Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997 [TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability and pharmacokinetics of two oral formulations of flurbiprofen: a single-dose, randomized, open-label, two-period, crossover study in Pakistani subjects. Qayyum A; Najmi MH; Abbas M Pak J Pharm Sci; 2013 Nov; 26(6):1221-7. PubMed ID: 24191330 [TBL] [Abstract][Full Text] [Related]
4. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations. Pargal A; Kelkar MG; Nayak PJ Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042 [TBL] [Abstract][Full Text] [Related]
5. Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Geisslinger G; Lötsch J; Menzel S; Kobal G; Brune K Br J Clin Pharmacol; 1994 Apr; 37(4):392-4. PubMed ID: 8018462 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of flurbiprofen. Kaiser DG; Brooks CD; Lomen PL Am J Med; 1986 Mar; 80(3A):10-5. PubMed ID: 3963013 [TBL] [Abstract][Full Text] [Related]
7. Stereoselective pharmacokinetics of flurbiprofen in humans and rats. Jamali F; Berry BW; Tehrani MR; Russell AS J Pharm Sci; 1988 Aug; 77(8):666-9. PubMed ID: 3210154 [TBL] [Abstract][Full Text] [Related]
8. Bioavailability of flurbiprofen following buccal administration. Stalker DJ; Pollock SR Pharm Res; 1991 May; 8(5):605-7. PubMed ID: 1866375 [TBL] [Abstract][Full Text] [Related]
9. Human plasma concentrations of R, S, and racemic flurbiprofen given as a toothpaste. Forland SC; Wechter WJ; Witchwoot S; Clifford KH; Arnett RL; Cutler RE J Clin Pharmacol; 1996 Jun; 36(6):546-53. PubMed ID: 8809639 [TBL] [Abstract][Full Text] [Related]
10. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect. Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136 [TBL] [Abstract][Full Text] [Related]
11. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Kang JH; Oh DH; Oh YK; Yong CS; Choi HG Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic interaction between flurbiprofen and antacids in healthy volunteers. Caillé G; du Souich P; Vézina M; Pollock SR; Stalker DJ Biopharm Drug Dispos; 1989; 10(6):607-15. PubMed ID: 2611360 [TBL] [Abstract][Full Text] [Related]
13. Disposition of flurbiprofen in man: influence of stereochemistry and age. Patel BK; Jackson SH; Swift CG; Hutt AJ Xenobiotica; 2003 Oct; 33(10):1043-57. PubMed ID: 14555340 [TBL] [Abstract][Full Text] [Related]
14. Multiple dosing increases the ocular bioavailability of topically administered flurbiprofen. Anderson JA; Chen CC Arch Ophthalmol; 1988 Aug; 106(8):1107-9. PubMed ID: 3401139 [TBL] [Abstract][Full Text] [Related]
15. Enhanced oral bioavailability of flurbiprofen by combined use of micelle solution and inclusion compound. Li DX; Han MJ; Balakrishnan P; Yan YD; Oh DH; Joe JH; Seo Y; Kim JO; Park SM; Yong CS; Choi HG Arch Pharm Res; 2010 Jan; 33(1):95-101. PubMed ID: 20191350 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of flurbiprofen in younger and elderly patients with rheumatoid arthritis. Kean WF; Antal EJ; Grace EM; Cauvier H; Rischke J; Buchanan WW J Clin Pharmacol; 1992 Jan; 32(1):41-8. PubMed ID: 1740536 [TBL] [Abstract][Full Text] [Related]
17. Dose-dependency of flurbiprofen enantiomer pharmacokinetics in the rat. Jamali F; Berry BW; Wright MR J Pharm Sci; 1994 Aug; 83(8):1077-80. PubMed ID: 7983589 [TBL] [Abstract][Full Text] [Related]
18. A randomised, two-period, cross-over, open-label study to evaluate the pharmacokinetic profiles of single doses of two different flurbiprofen 8.75-mg lozenges in healthy volunteers. Matzneller P; Burian A; Martin W; Annoni O; Lauro V; Tacchi R; Brunner M; Zeitlinger M Pharmacology; 2012; 89(3-4):188-91. PubMed ID: 22433300 [TBL] [Abstract][Full Text] [Related]
19. Chiral pharmacokinetics of Rac-flurbiprofen and pharmacodynamics of anabolic bone response in the normal rat. Wechter WJ; Bigornia AE; Murray ED; Jee WS Chirality; 1994; 6(6):457-9. PubMed ID: 7946972 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic comparison of oral and local action transcutaneous flurbiprofen in healthy volunteers. Taburet AM; Singlas E; Glass RC; Thomas F; Leutenegger E J Clin Pharm Ther; 1995 Apr; 20(2):101-7. PubMed ID: 7650070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]